Johnson & Johnson (J&J) received a binding offer of $2.7 billion in cash from Fortive Corp. for the acquisition of its Advanced Sterilization Products (ASP) business, a division of Ethicon Inc. This is just the latest big-ticket medical device business divestiture from J&J; last quarter it reported it would sell its Lifescan business to private equity firm Platinum Equity for $2.1 billion.